Rejection Clinical Trials in Chicago, Illinois
6 recruitingChicago, Illinois
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
Lung Transplant Rejection
Sanofi180 enrolled80 locationsNCT06082037
Recruiting
Phase 1
Treatment of Antibody-Mediated Rejection (ABMR) With CarBel
Kidney Transplant Rejection
National Institute of Allergy and Infectious Diseases (NIAID)25 enrolled10 locationsNCT06918990
Recruiting
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Chronic Kidney DiseaseLiver TransplantHepatitis C+1 more
Northwestern University1,000 enrolled1 locationNCT01644903
Recruiting
Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients
Acute Rejection (AR) of Transplanted KidneyChronic Allograft Nephropathy (CAN)Interstitial Fibrosis (IF)+1 more
Northwestern University1,000 enrolled1 locationNCT01531257
Recruiting
Phase 2
A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR)
Antibody-mediated Rejection
argenx30 enrolled23 locationsNCT06503731
Recruiting
Phase 3
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)
Antibody-mediated Rejection
Biogen120 enrolled59 locationsNCT06685757